Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Other base/diluent/suspending agent/stabiliser preparations
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Generic Methadose diluent oral solution sugar free
190700000AABJBJ
|
Generic compound preparation BNF 1907000 | Other base/diluent/suspending agent/stabiliser preparations | Other Drugs and Preparations | 2 |
|
Methadose diluent oral solution sugar free
190700000BBBPBJ
|
Proprietary compound preparation BNF 1907000 | Other base/diluent/suspending agent/stabiliser preparations | Other Drugs and Preparations | 2 |
|
ORA-Plus oral suspension
190700000BBCQA0
|
Proprietary compound preparation BNF 1907000 | Other base/diluent/suspending agent/stabiliser preparations | Other Drugs and Preparations | 2 |
|
Nutilis powder 12g sachets
190700000BBCKBA
|
Proprietary compound preparation BNF 1907000 | Other base/diluent/suspending agent/stabiliser preparations | Other Drugs and Preparations | 1 |
|
Thick & Easy Original powder 9g sachets
190700000BBBTBA
|
Proprietary compound preparation BNF 1907000 | Other base/diluent/suspending agent/stabiliser preparations | Other Drugs and Preparations | 1 |
|
Nutilis Clear powder 3g sachets
190700000BBCWBA
|
Proprietary compound preparation BNF 1907000 | Other base/diluent/suspending agent/stabiliser preparations | Other Drugs and Preparations | No data available |
|
SLO Drink 3 oral powder
190700000BBCHA0
|
Proprietary compound preparation BNF 1907000 | Other base/diluent/suspending agent/stabiliser preparations | Other Drugs and Preparations | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.